A clinical trial on Maruthampattai chooranam and Arugankattai kudineer chooranam in the management of Hypertension

Effectiveness of Maruthampattai chooranam and Arugankattai kudineer chooranam in the management of Essential Hypertension among the patients attending Ayothidoss Pandithar Hospital, NIS-A Proof-of-Concept study. - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/0103120

Enrollment

Registered

2026-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: 1.Maruthampattai chooranam 2.Arugankattai kudineer chooranam: 30g Maruthampattai chooranam and 70g Arugankattai chooranam will be dispensed once in 7 days for 48 days. Control Interven

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 59 years(All gender) Stage 1 Hypertension(According to JNC Guidelines)

Exclusion criteria

Exclusion criteria: Age above 60 years K/c/o liver disease kidney disease Hematopoietic disease malignant tumour cardiovascular disease cerebrovascular disease white collar hypertension stage 2 hypertension pregnant woman patients taking anti-hypertensive medications

Design outcomes

Primary

Measure	Time frame
To evaluate the clinical effectiveness of siddha formulations Maruthampattai chooranam and Arugankattai kudineer chooranam in the managemnet of Essential hypertension through mercury sphygmomanometerTimepoint: 6 months	—

Secondary

Measure	Time frame
To assess the changes in lipid profile before and after treatmentTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDrSVisweswaran

National Institute of Siddha

svisu11@gmail.com9962542755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026